Capillary versus venous blood sampling for clozapine blood levels: a practice based study comparing patients experiences, measurement outcomes and costs.

Capillary versus venous blood sampling for clozapine blood levels: a practice based study comparing patients experiences, measurement outcomes and costs. - FAst Clozapine blood LEvel test study (FACILE)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49486

Enrollment

Registered

2020-09-24

Start date

2020-11-01

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychotic disorder schizofrenie

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients aged 18 years of age or older, receiving clozapine for schizophrenia or schizo-affective disorder, accessible for treatment and follow-up and able (investigated by the treating physician) or willing to participate/giving informed consent for participation in this study.

Exclusion criteria

Exclusion criteria: Patients acutely involuntary admitted to the hospital (In Dutch: Crisismaatregel, former IBS), patients and/or not able or willing to give their informed consent (In Dutch: wilsonbekwaam inzake afweging participatie in dit onderzoek)

Design outcomes

Primary

Measure	Time frame
patients complete questionnaires on their experience using a VAS scale., risks are negligible (only one extra capillary prick besides regularly performed venous blood sample drawing) and therefore the burden is minimal and the study is group related (study can only be done using these patients groups).	—

Secondary

Measure	Time frame
Correlation between serum values of clozapine and cost-effectiveness of point of care testing for clozapine.	—

Countries

Netherlands

Outcome results